Latest filing published 07 Jan 2026 for NRC HEALTH, €119k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michael D. Hays: trading record in brief
This profile gathers the share dealings of Michael D. Hays in NRC Health, where the filings describe the role as chief executive. The record holds 168 filings, for trades running from 1 December 2010 to 5 January 2026.
Market trades split into 1 purchase (€56.2M) and 90 sales (€267.0M). Sales outweigh purchases by €210.8M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 11 share grants and 20 option exercises.
Most recently, on 7 January 2026, the filings show an option exercise worth €119k in NRC Health. The most recent open-market purchase was published on 3 December 2010, 5,819 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Michael D. Hays
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,145 shares@ US$15.2326.8% of flowCommon StockSEC:0001008886-26-000008:0
- 10,014 shares@ US$13.1728.7% of flowCommon StockSEC:0001008886-25-000012:0
- 1,909 shares@ US$39.560.0% of flowCommon StockSEC:0001008886-24-000024:1
- 2,904 shares@ US$18.8011.1% of flowCommon StockSEC:0001008886-24-000024:0
- 45,040 shares0Common StockSEC:0001008886-23-000036:0
- 7,000 shares0Common StockSEC:0001567619-23-004078:1
- 19,000 shares0Common StockSEC:0001567619-23-004078:0
- 10,938 shares@ US$14.5033.4% of flowCommon StockSEC:0001567619-23-000524:0
- 14,949 shares@ US$10.750.1% of flowCommon StockSEC:0001567619-21-022532:1
- 7,596 shares@ US$40.070.2% of flowCommon StockSEC:0001567619-21-022532:2
- 10,500 shares0Common StockSEC:0001567619-21-022532:0
- 17,745 shares@ US$9.140.1% of flowCommon StockSEC:0001567619-21-000544:0
- 11,403 shares@ US$52.5429.1% of flowCommon StockSEC:0001567619-20-018764:0
- 26,481 shares@ US$6.306.8% of flowCommon StockSEC:0001567619-20-000712:0
- 10,962 shares@ US$65.8029.4% of flowCommon StockSEC:0001567619-20-000712:1
- 20,109 shares@ US$8.130.1% of flowCommon StockSEC:0001567619-19-000704:0
- 9,098 shares@ US$38.080.2% of flowCommon StockSEC:0001567619-19-000704:1
- 80 shares@ US$35.000.0% of flowCommon StockSEC:0001140361-18-019522:0
- 125 sharesClass B Common StockSEC:0001140361-18-018958:0
- 125 sharesCommon StockSEC:0001140361-18-018958:1
- 12 sharesClass B Common StockSEC:0001140361-18-018958:2
- 12 sharesCommon StockSEC:0001140361-18-018958:3
- 3,870 sharesCommon StockSEC:0001140361-18-018958:4
- 1,799 shares@ US$33.550.0% of flowCommon StockSEC:0001140361-18-018958:5
- 5,261,410 shares@ US$19.3155.5% of flowClass A Common StockSEC:0001140361-18-008926:0
25 of 166 declarations